Associate Vice President - Global Marketing Oncology @ (October 2020 - October 2021)
Executive Director - Global Head New Products and Business Development @ (October 2018 - October 2020)
Senior Director - Early Commercial Strategy @ (October 2016 - September 2018)
Senior Director - Global AFINITOR Brand Lead - Rare Diseases @ (March 2010 - October 2016)
Global Life Cycle Manager - AFINITOR @ Novartis Oncology (April 2008 - March 2010)
AFINITOR Commercial Lead @ Novartis Oncology (February 2005 - March 2008)
Marketing Head - Novartis Oncology France @ Novartis Oncologie France (December 1999 - January 2005)
Philippe Ledru Education
ESSEC - ESSEC Business School
graduate (Chaire ESSEC Sante
Chaire Ventes et Strategies Commerciales)
1989-1991
Ecole nationale vétérinaire de Nantes
Doctorate (Osteology Club
The student Farm)
1983-1988
Philippe Ledru Skills
Market Access
Hematology
Oncology
Global Marketing
Product Development
Product Life Cycle Management
Marketing Strategy
Strategic Planning
Product Launch
Strategy Development
Business Strategy
Marketing Management
Orphan Drugs
Pediatric Neurology
Urology
Nephrology
Dermatology
Pulmonology
Rare Diseases
Strategy
Pharmaceutical Industry
Pharmaceutical Sales
Clinical Trials
Segmentation
Product Lifecycle Management
Commercialization
Medical Affairs
Hospital Sales
Clinical Development
Rheumatology
Change Management
Trials
Communication
Marketing
Philippe Ledru Summary
Philippe Ledru, based in Madison, NJ, US, is currently a Senior Vice President - Chief Commercial Officer at Aptose Biosciences, Inc.. Philippe Ledru brings experience from previous roles at Merck, Novartis Oncology and Novartis. Philippe Ledru holds a 1989 - 1991 graduate in Chaire ESSEC Sante
Chaire Ventes et Strategies Commerciales @ ESSEC - ESSEC Business School. With a robust skill set that includes Market Access, Hematology, Oncology, Global Marketing, Product Development and more. Philippe Ledru has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Philippe Ledru?
Find contact details for 700 million professionals.